News Amid political tumult, a new leader for Europe’s pharma indu... The European pharma industry has appointed a new leader – just as EU politicians face their greatest test in a generation
News New radiopharma Actithera emerges with $75.5m in financing A new player in radioligand therapies, Actithera, has arrived on the scene with $75.5m in funding and lead FAP-targeted candidate for cancer.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
